INMB logo

INmune Bio Inc. Common stock


INMB: INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.


Show INMB Financials

Consumer Interest
SEC Filings

Recent trades of INMB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by INMB's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of INMB in WallStreetBets Daily Discussion


Recent insights relating to INMB

CNBC Recommendations

Recent picks made for INMB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INMB

Corporate Flights

Flights by private jets registered to INMB